Ischemic Preconditioning for Prevention of Contrast Medium–Induced Nephropathy
Author(s) -
Fikret Er,
Amir M. Nia,
Henning Dopp,
Martin Hellmich,
Kristina M. Dahlem,
Evren Caglayan,
Torsten Kubacki,
Thomas Benzing,
Erland Erdmann,
Volker Burst,
Natig Gassanov
Publication year - 2012
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.112.096370
Subject(s) - medicine , ischemic preconditioning , acute kidney injury , contrast induced nephropathy , renal function , odds ratio , creatinine , ischemia , contrast medium , nephropathy , randomized controlled trial , renal ischemia , blood pressure , cardiology , anesthesia , surgery , myocardial infarction , reperfusion injury , percutaneous coronary intervention , diabetes mellitus , radiology , endocrinology
Contrast medium-induced acute kidney injury is associated with substantial morbidity and mortality. The underlying mechanism has been attributed in part to ischemic kidney injury. The aim of this randomized, double-blind, sham-controlled trial was to assess the impact of remote ischemic preconditioning on contrast medium-induced acute kidney injury.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom